Tumor growth modulates macrophage nitric oxide production following paclitaxel administration

International Journal of Immunopharmacology

Volumn 20, Issue 10, 1998, Pages 537-551

  Mullins, D W ^a   Burger, C J ^a   Elgert, K D ^a  

^a Microbiol and Immunol Sect V   (United States)

Author keywords

Cytotoxicity; Macrophages; Nitric oxide; Paclitaxel; Tumor necrosis factor

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; NITRIC OXIDE; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOTHERAPY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYTOTOXICITY, IMMUNOLOGIC; INTERFERON TYPE II; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PACLITAXEL; SARCOMA, EXPERIMENTAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031772037     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00047-2     Document Type: Article

References (45)

1. Adams D. O., Hamilton T. A. Immunolog. Rev. 97:1987;5-27.
2. Ahmed S. A., Gogal R. M. Jr., Walsh J. E. J. Immunolog. Meth. 171:1994;211-224.
3. Albina J. E., Abate J. A., Henry W. L. Jr. J. Immunol. 147:1991;144-148.
4. Alleva D. G., Askew D., Burger C. J., Elgert K. D. J. Leukoc. Biol. 54:1993;152-160.
5. Alleva D. G., Burger C. J., Elgert K. D. J. Immunol. 153:1994;1674-1686.
6. Bauer H., Jung T., Tsikas D., Stichtenoth D. O., Frolich J. C., Neumann C. Immunology. 90:1997;205-211.
7. Beissert S., Bergholz M., Waase I., Lepsien G., Schauer A., Pfizenmaier K., Kronke M. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5064-5068.
8. Cox G. W., Melillo G., Chattopadhyay U., Mullet D., Fertel R. H., Varesio L. J. Immunol. 149:1992;3290-3296.
9. Denis M. J. Leukoc. Biol. 55:1994;682-684.
10. DiNapoli M. R., Calderon C. L., Lopez D. M. J. Exp. Med. 183:1996;1323-1329.
11. Donaldson K. L., Goolsby G. L., Wahl A. F. Int. J. Cancer. 57:1994;847-855.
12. Dorr R. T. Ann. Pharmacother. 11:1994;14.
13. Duffie G. P., Young M. R. I. J. Leukoc. Biol. 49:1991;8-14.
14. Dugas B., Mossalayi M. D., Damais C., Kolb J.-P. Immunol. Today. 16:1995;574-580.
15. Elgert K. D., Connolly K. M. Cell. Immunol. 35:1978;1-14.
16. Elgert K. D., Farrar W. L. J. Immunol. 120:1978;1345-1353.
17. Fast D. J., Lynch R. C., Leu R. W. J. Leukoc. Biol. 52:1992;255-261.
18. Francis P., Rowinsky E., Schneider J., Hakes T., Hoskins W. J. Clin. Oncol. 13:1995;2961-2967.
19. Fuchs D. A., Johnson R. K. Cancer Treat. Rep. 62:1978;1219-1222.
20. Ghezzi P., Erroi A., Acero R., Salmona M., Mantovani A. J. Leukoc. BIol. 42:1987;84-90.
21. Gorelik L., Bar-Dagan Y., Mokyr M. B. J. Immunol. 156:1996;4298-4308.
22. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Anal. Biochem. 126:1982;131-138.
23. Gregory S. H., Sagnimeni A. J., Wing E. J. Cell Immunol. 153:1994;527-532.
24. Hajek R., Vorlicek J., Slavik M. Neoplasma. 43:1996;141-154.
25. Hibbs J. B. Jr., Taintor R.R., Vavrin Z., Rachlin E. M. Biochem. Biophys. Res. Commun. 157:1988;87-94.
26. Kingston D. G. I. Pharmacol. Ther. 52:1991;1-33.
27. Kingston D. G. I. Trends Biotech. 12:1997;222-227.
28. Leu R. W., Leu N. R., Shannon B. J., Fast D. J. J. Immunol. 147:1991;1816-1822.
29. Ma, X., Aste-Amezaga, M., and Trinchieri, G. (1996). Regulation of interleukin-12 production. In Lotze, M. T., Trinchieri, G., Gately, M., Wolf, S. (Eds.), Interleukin-12: Cellular and molecular immunology of an important regulatory cytokine. New York Academy of Sciences: New York, pp.13-35.
30. Manfredi J. J., Parness J., Horwitz S. B. J. Cell Biol. 94:1982;688-696.
31. Manthey C. L., Brandes M. E., Perera P.-Y., Vogel S. N. J. Immunol. 149:1992;2459-2465.
32. Manthey C. L., Perera P.-Y., Salkowski C. A., Vogel S. N. J. Immunol. 152:1994;825-831.
33. Mantovani A., Ming W. J., Batotta C., Abdeljali B., Botazzi B. Biochim. Biophys. Acta. 865:1986;59-67.
34. Mills C. D., Shearer J., Evans R., Caldwell M. D. J. Immunol. 149:1992;2709-2714.
35. Moncada S., Palmer R. M. J., Hibbs E. A. Pharmacol. Rev. 43:1991;109-134.
36. Mosmann T. J. Immunolog. Meth. 65:1983;55-63.
37. Mullins D. W., Alleva D. G., Burger C. J., Elgert K. D. Immunopharmacology. 37:1997;63-73.
38. Mullins D. W., Walker T. M., Burger C. J., Elgert K. D. Cancer Immunol. Immunother. 45:1997;20-28.
39. Neta R., Sayers T. J., Oppenheim J. J. Immunol. Ser. 56:1992;499-566.
40. Nicolaou K. C., Yang Z., Liu J. J., Ueno H., Nantermet P. G., Guy R. K., Claiborne C. F., Renaud J., Couladouros E. A., Paulvannan K., Sorensen E. J. Nature. 367:1994;630-634.
41. Rowinsky E. K., Donehower R. C., Jones R. J., Tucker R. W. Cancer Res. 48:1988;4093-4100.
42. Rowinsky E. K., Eisenhauer E. A., Chaudhry V., Arbuck S. G., Donehower R. C. Taxol. Semin. Oncol. 20:1993;1-15.
43. Szebeni J., Muggia F. M., Alving C. R. J. Natl. Cancer Inst. 90:1998;300-306.
44. Wani M. C., Taylor H. L., Wall M. E., Coggan P., McPhail A. T. VI. The isolation and structure of taxol. 93:1971;2325-2327.
45. Weinberg J. B., Misukonis M. A., Shami P. J., Mason S. N., Sauls D. L., Dittman W. A., Wood E. R., Smith G. K., McDonald B., Bachus K. E., Haney A. F., Granger D. L. Blood. 86:1995;1184-1195.